NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at the New York Academy of Sciences

COSTA MESA, CA., March 07, 2018 (GLOBE NEWSWIRE) — NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced today that Dr. Brian Murphy, CEO and Chief Medical Officer, will participate at the 2018 Sachs BioCapital USA Forum at the New York Academy of Sciences, on March 21, 2018 in New York City. The Academy, founded in 1817, fosters scientific excellence globally and counts thirty-six Nobel laureates among its President’s Council. Dr. Murphy, a member of the New York Academy of Sciences, will provide a corporate overview presentation of the Nemus bio-engineered cannabinoid portfolio at 3:20 PM EST and will also participate in a CEO Plenary Panel at 1:30 PM EST titled “Medical Cannabis: Clinical Development Strategies and Programs”. The event will also include one-to-one meetings coordinated by the conference organizers among the participants from global pharmaceutical companies and innovative biotech firms.

Source: NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at the New York Academy of Sciences

Innovest Global, Inc. Forms Biotech Subsidiary To Be Led By World-Renowned Neuroscientist, Dr. Dwain Morris-Irvin – Spotlight Growth

Sacramento, CA, March 07, 2018 (GLOBE NEWSWIRE) — A new report has been published on Innovest Global, Inc. (OTC Pink: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. The company’s planned subsidiaries operate across telehealth, biotech, commercial energy, business-to-business distribution, national call center and auto sales.

Source: Innovest Global, Inc. Forms Biotech Subsidiary To Be Led By World-Renowned Neuroscientist, Dr. Dwain Morris-Irvin – Spotlight Growth

RAPPEL : Papiers Tissu KP inc. publiera ses résultats financiers et ceux de Produits Kruger S.E.C pour le quatrième trimestre de l'exercice 2017

MISSISSAUGA, ONTARIO–(Marketwired – 7 mars 2018) – Papiers Tissu KP inc. (TSX:KPT) (« PTKP »), qui détient un intérêt limité dans Produits Kruger S.E.C (« PK S.E.C. »), publiera les résultats financiers de PTKP et de PK S.E.C. pour le quatrième trimestre de l’exercice 2017 le jeudi 8 mars 2018, avant l’ouverture de la séance. PTKP tiendra une téléconférence cette même journée, à 8 h 30, heure normale de l’Est.
Source: RAPPEL : Papiers Tissu KP inc. publiera ses résultats financiers et ceux de Produits Kruger S.E.C pour le quatrième trimestre de l'exercice 2017

REMINDER: KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the Fourth Quarter of 2017

MISSISSAUGA, ONTARIO–(Marketwired – March 7, 2018) – KP Tissue Inc. (“KPT”) (TSX:KPT), which holds a limited partnership interest in Kruger Products L.P. (“KPLP”), will release the financial results for KPT and KPLP for the fourth quarter of 2017 on Thursday March 8, 2018 before the market opens. KPT will hold its conference call the same day at 8:30 a.m. Eastern Time.
Source: REMINDER: KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the Fourth Quarter of 2017

Asia-Pacific Newswire